Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun 13:10:1517-1526.
doi: 10.2147/CMAR.S154819. eCollection 2018.

Fertility preservation in Hodgkin's lymphoma patients that undergo targeted molecular therapies: an important step forward from the chemotherapy era

Affiliations
Review

Fertility preservation in Hodgkin's lymphoma patients that undergo targeted molecular therapies: an important step forward from the chemotherapy era

Alexandra Traila et al. Cancer Manag Res. .

Abstract

In total, 80%-90% of Hodgkin's lymphoma (HL) patients are curable with combination chemoradiotherapy. Due to improvements in therapeutic strategies, 50% of all relapsed/refractory patients may undergo complete clinical responses and have long-term survival. Treatment options for HL are effective, but may have a negative impact on post-chemotherapy fertility. Thus, cryopreservation of semen prior to treatment is recommended for male patients. For female patients, assisted reproductive techniques (ART) consult and fertility preservation should be offered as a therapeutical option. In the last years, new targeted molecules have been available for HL treatment. These new drugs showed a high rate of overall responses in the setting of heavily pretreated patients, most of them in relapse after autologous stem cell transplantation, a group previously considered very poor risk. Up to 50% of patients have a complete response and an improved overall survival. Future studies will address the usefulness of novel molecules as a frontline therapy. Considering the high response and survival rates with monoclonal antibody-based therapeutics, fertility has become a concerning issue for long-term HL survivors. As progress has been made regarding ART, with the rigorous steps planned for HL patients, more survivors will become parents.

Keywords: Hodgkin’s lymphoma; fertility preservation; infertility; pregnancy.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Algorithm for fertility preservation in HL patients, at diagnosis. Abbreviations: HL, Hodgkin’s lymphoma; ABVD, doxorubicine, bleomycin, vinblastine, dacarbazine; Esc BEACOPP, escalated bleomycine, etoposide, doxorubicine, cyclophosphamide, vincristine, procarbazine, prednisone; ART, assisted reproductive techniques.
Figure 2
Figure 2
Algorithm for fertility preservation in relapsed/refractory HL patients. Abbreviations: HL, Hodgkin’s lymphoma; ASCT, autologous stem cell transplantation.

References

    1. Engert A, Diehl V, Franklin J, et al. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin’s lymphoma: 10 years of follow-up of the GHSG HD9 study. J Clin Oncol. 2009;27(27):4548–4554. - PubMed
    1. Donato EM, Fernandez-Zarzoso M, De La Rubia J. Immunotherapy for the treatment of Hodgkin lymphoma. Expert Rev Hematol. 2017;10(5):417–423. - PubMed
    1. Phillips T, Mercer J. Surveillance scans in lymphoma: friend or foe? Curr Treat Options Oncol. 2017;18(2):10. - PubMed
    1. Johnson P, Longley J. Should response-adapted therapy now be the standard of care for advanced Hodgkin’s lymphoma? Curr Treat Options Oncol. 2017;18(3):15. - PMC - PubMed
    1. Brammer JE, Khouri I, Gaballa S, et al. Outcomes of haploidentical stem cell transplantation for lymphoma with melphalan-based conditioning. Biol Blood Marrow Transplant. 2016;22(3):493–498. - PubMed

LinkOut - more resources